Literature DB >> 27734596

Longer warm ischemia can accelerate tumor growth through the induction of HIF-1α and the IL-6-JAK-STAT3 signaling pathway in a rat hepatocellular carcinoma model.

Yuhei Hamaguchi1, Akira Mori1, Yasuhiro Fujimoto1, Takashi Ito1, Taku Iida1, Shintaro Yagi1, Hideaki Okajima1, Toshimi Kaido1, Shinji Uemoto1.   

Abstract

BACKGROUND: The present study aimed to investigate the impact of the duration of hepatic pedicle clamping (HPC) on tumor growth after major hepatectomy in a rat model.
METHODS: Rats were divided into four groups according to the length of HPC during 70% partial hepatectomy followed by N1S1 tumor cell implantation: group 1, without HPC; group 2, with 5-min HPC; group 3, 10-min HPC; and group 4, 15-min HPC. At three weeks after tumor cell implantation, liver tumor growth and its possible mechanisms were investigated.
RESULTS: The number and largest diameter of liver tumor were significantly greater in group 4. At 6 h after reperfusion, serum levels of inflammatory cytokines including interleukin (IL)-6 were significantly higher in group 4 compared with the other groups. In the tumor tissues, the expression of hypoxia inducible factor (HIF)-1α (P < 0.001 versus group 2, P < 0.001 versus group 3) and that of phospho-signal transducer and activator of transcription 3 (STAT3) (P < 0.001 versus group 2, P = 0.026 versus group 3) were significantly upregulated in group 4.
CONCLUSIONS: Longer HPC followed by reperfusion accelerated hepatocellular carcinoma growth through the induction of HIF-1α and the activation of the IL-6-JAK-STAT3 signaling pathway.
© 2016 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Hepatic ischemia-reperfusion injury; Hepatocellular carcinoma; Hypoxia inducible factor-1α; Interleukin-6; Janus kinases and signal transducer and activator of transcription 3 pathway

Mesh:

Substances:

Year:  2016        PMID: 27734596     DOI: 10.1002/jhbp.406

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  4 in total

1.  miR-1-3p and miR-206 sensitizes HGF-induced gefitinib-resistant human lung cancer cells through inhibition of c-Met signalling and EMT.

Authors:  Demin Jiao; Jun Chen; Yu Li; Xiali Tang; Jian Wang; Wei Xu; Jia Song; You Li; Huimin Tao; Qingyong Chen
Journal:  J Cell Mol Med       Date:  2018-04-17       Impact factor: 5.310

2.  IL-6 and NFE2L2: A putative role for the hepatoprotective effect of N. Sativa, P. Ginseng and C. Sempervirens in AFB-1 induced hepatocellular carcinoma in rats.

Authors:  Nora M Aborehab; Nermien E Waly
Journal:  Toxicol Rep       Date:  2019-05-21

3.  Ischemia-reperfusion injury and the risk of hepatocellular carcinoma recurrence after deceased donor liver transplantation.

Authors:  Michał Grąt; Marek Krawczyk; Karolina M Wronka; Jan Stypułkowski; Zbigniew Lewandowski; Michał Wasilewicz; Piotr Krawczyk; Karolina Grąt; Waldemar Patkowski; Krzysztof Zieniewicz
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

4.  Circ_0038467 regulates lipopolysaccharide-induced inflammatory injury in human bronchial epithelial cells through sponging miR-338-3p.

Authors:  Guangming Liu; Qiufeng Wan; Jingwen Li; Xinying Hu; Xingli Gu; Sicheng Xu
Journal:  Thorac Cancer       Date:  2020-03-17       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.